Literature DB >> 12823385

Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction.

L Sandfeldt1, R G Hahn.   

Abstract

OBJECTIVE: To study whether the risk profile for cardiovascular disease correlates with prostate size in elderly men seeking medical attention for lower urinary tract symptoms (LUTS), by assessing physiological, biochemical and personality traits. PATIENTS AND METHODS: Fifty-two men (mean age 68 years, range 52-85) with bladder outlet obstruction, as verified by urodynamic testing, had their prostate size measured by transrectal ultrasonography. Their blood and urine was also examined, and their personality and heart rate variability tested. The measured variables were assessed statistically in relation to whether the prostate volume was smaller (22 men) or larger (30 men) than 50 mL.
RESULTS: Patients with a large prostate (mean 104 mL) had a higher mean arterial pressure (105 vs 95 mmHg, P < 0.01), and serum glucose (5.3 vs 4.8 mmol/L, P < 0.01) and serum cortisol (423 vs 362 nmol/L, P = 0.06) concentrations than those with a small gland (mean 31 mL). The personality test showed that they were also less assertive than the others (P < 0.03). The components of the heart rate variability indicated that men with a large prostate had increased sympathetic activity.
CONCLUSION: Men with LUTS caused by a very large prostate have more risk factors for cardiovascular disease than those with a smaller gland.

Entities:  

Mesh:

Year:  2003        PMID: 12823385     DOI: 10.1046/j.1464-410x.2003.04277.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study.

Authors:  Inge I Bouwman; Marco H Blanker; Boris W V Schouten; Arthur M Bohnen; Rien J M Nijman; Wouter K van der Heide; J L H Ruud Bosch
Journal:  World J Urol       Date:  2014-09-25       Impact factor: 4.226

2.  Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.

Authors:  Aruna V Sarma; Jennifer L St Sauver; John M Hollingsworth; Debra J Jacobson; Michaela E McGree; Rodney L Dunn; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2011-11-23       Impact factor: 2.649

Review 3.  Cholesterol and benign prostate disease.

Authors:  Michael R Freeman; Keith R Solomon
Journal:  Differentiation       Date:  2011-08-20       Impact factor: 3.880

Review 4.  Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis.

Authors:  Iris I Bouwman; Maarten J H Voskamp; Boudewijn J Kollen; Rien J M Nijman; Wouter K van der Heide; Marco H Blanker
Journal:  World J Urol       Date:  2015-05-14       Impact factor: 4.226

5.  Association of lower urinary tract syndrome with peripheral arterial occlusive disease.

Authors:  Wei-Yu Lin; Karl-Erik Andersson; Cheng-Li Lin; Chia-Hung Kao; Hsi-Chin Wu
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

6.  High degree of prostate related LUTS in a prospective cross-sectional community study in Ghana (Mamprobi).

Authors:  George A Asare; Derick S Sule; Jared N Oblitey; Reese Ntiforo; Bernice Asiedu; Brodrick Y Amoah; Emmanuel L Lamptey; Daniel K Afriyie; Benard Ohene Botwe
Journal:  Heliyon       Date:  2021-11-14

7.  Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.

Authors:  Inge I Bouwman; Boudewijn J Kollen; Klaas van der Meer; Rien J M Nijman; Wouter K van der Heide
Journal:  BMC Fam Pract       Date:  2014-01-14       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.